High Prescribing: A Case Study of High-Potency Medicinal Cannabis Inducing Psychosis
Richard C. J. Bradlow, Sophie Wright, Anamaria Szrajbman Vaz Da Silva, Ferghal Armstrong · 2024
Read High Prescribing: A Case Study of High-Potency Medicinal Cannabis Inducing Psychosis by Richard C. J. Bradlow, Sophie Wright, Anamaria Szrajbman Vaz Da Silva, Ferghal Armstrong (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11646144.txt.
Description
Richard C J Bradlow and three co-authors report the first published Australian case of psychosis blamed on prescribed cannabis. Their 2024 case study opens with a warning about context: medical cannabis prescribing has climbed steeply in Australia on weak evidence for its common uses. Their patient, a twenty-one-year-old Indigenous man, switched from street cannabis to a prescribed high-potency product.
He then developed a fixed jealous delusion about his partner, turned violent toward her, and tried to end his own life. The authors stress that the psychosis risk follows the drug, not its legal status, and that prescribed users face an added risk of cannabis use disorder. Their advice to prescribers is concrete: screen for family history of psychosis, review patients regularly, and give harm-reduction counsel. They close by calling for tighter regulation of prescribing and more research on its spread.
Catalog record
| CREATOR | Richard C. J. Bradlow, Sophie Wright, Anamaria Szrajbman Vaz Da Silva, Ferghal Armstrong |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 8 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |